• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片受体的寡聚化

Oligomerization of opioid receptors.

作者信息

Gomes Ivone, Filipovska Julija, Jordan Bryen A, Devi Lakshmi A

机构信息

Department of Pharmacology, New York University School of Medicine, MSB 408, New York 10016, USA.

出版信息

Methods. 2002 Aug;27(4):358-65. doi: 10.1016/s1046-2023(02)00094-4.

DOI:10.1016/s1046-2023(02)00094-4
PMID:12217652
Abstract

Opioid receptors belong to the family of G-protein-coupled receptors characterized by their seven transmembrane domains. The activation of these receptors by agonists such as morphine and endogenous opioid peptides leads to the activation of inhibitory G-proteins followed by a decrease in the levels of intracellular cAMP. Opioid receptor activation is also associated with the opening of K(+) channels and the inhibition of Ca(2+) channels. A number of investigations, prior to the development of opioid receptor cDNAs, suggested that opioid receptor types interacted with each other. Early pharmacological studies provided evidence for the probable interaction between opioid receptors. More recent studies using receptor selective antagonists, antisense oligonucleotides, or animals lacking opioid receptors further suggested that interactions between opioid receptor types could modulate their activity. We examined opioid receptor interactions using biochemical, biophysical, and pharmacological techniques. We used differential epitope tagging and selective immunoisolation of receptor complexes to demonstrate homotypic and heterotypic interactions between opioid receptor types. We also used the proximity-based bioluminescence resonance energy transfer assay to explore opioid receptor-receptor interactions in living cells. In this article we describe the biochemical and biophysical methods involved in the detection of receptor dimers. We also address some of the concerns and suggest precautions to be taken in studies examining receptor-receptor interactions.

摘要

阿片受体属于G蛋白偶联受体家族,其特征为具有七个跨膜结构域。吗啡和内源性阿片肽等激动剂激活这些受体后,会导致抑制性G蛋白的激活,随后细胞内cAMP水平降低。阿片受体激活还与K(+)通道的开放和Ca(2+)通道的抑制有关。在阿片受体cDNA开发之前的一些研究表明,阿片受体类型之间会相互作用。早期的药理学研究为阿片受体之间可能的相互作用提供了证据。最近使用受体选择性拮抗剂、反义寡核苷酸或缺乏阿片受体的动物进行的研究进一步表明,阿片受体类型之间的相互作用可以调节它们的活性。我们使用生化、生物物理和药理学技术研究阿片受体相互作用。我们使用差异表位标签和受体复合物的选择性免疫分离来证明阿片受体类型之间的同型和异型相互作用。我们还使用基于邻近的生物发光共振能量转移测定法来探索活细胞中的阿片受体-受体相互作用。在本文中,我们描述了检测受体二聚体所涉及的生化和生物物理方法。我们还讨论了一些问题,并对研究受体-受体相互作用时应采取的预防措施提出了建议。

相似文献

1
Oligomerization of opioid receptors.阿片受体的寡聚化
Methods. 2002 Aug;27(4):358-65. doi: 10.1016/s1046-2023(02)00094-4.
2
G protein coupled receptor dimerization: implications in modulating receptor function.G蛋白偶联受体二聚化:对调节受体功能的影响
J Mol Med (Berl). 2001 Jun;79(5-6):226-42. doi: 10.1007/s001090100219.
3
Molecular biology of the opioid receptors: structures, functions and distributions.阿片受体的分子生物学:结构、功能与分布
Neurosci Res. 1995 Sep;23(2):121-45. doi: 10.1016/0168-0102(95)00933-k.
4
Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer.通过定量生物发光共振能量转移检测活细胞中的阿片受体同源和异源二聚化
Mol Pharmacol. 2005 Jun;67(6):2173-84. doi: 10.1124/mol.104.010272. Epub 2005 Mar 18.
5
Opioids in chronic pain.慢性疼痛中的阿片类药物。
Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. doi: 10.1016/s0014-2999(01)01308-5.
6
G-protein-coupled receptor dimerization: modulation of receptor function.G蛋白偶联受体二聚化:受体功能的调节
Pharmacol Ther. 2001 Nov-Dec;92(2-3):71-87. doi: 10.1016/s0163-7258(01)00160-7.
7
Monitoring opioid receptor dimerization in living cells by bioluminescence resonance energy transfer (BRET).通过生物发光共振能量转移(BRET)监测活细胞中的阿片受体二聚化。
Methods Mol Biol. 2015;1230:105-13. doi: 10.1007/978-1-4939-1708-2_8.
8
ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.ATP门控钾离子通道开放剂增强阿片类药物的镇痛作用:内源性阿片肽释放的间接证据。
Eur J Pharmacol. 1999 Dec 3;385(2-3):119-27. doi: 10.1016/s0014-2999(99)00618-4.
9
Molecular biology of opioid receptors: recent advances.阿片受体的分子生物学:最新进展
Neuroimmunomodulation. 1997 Sep-Dec;4(5-6):285-97. doi: 10.1159/000097349.
10
Oligomerization of opioid receptors: generation of novel signaling units.
Curr Opin Pharmacol. 2002 Feb;2(1):76-81. doi: 10.1016/s1471-4892(02)00124-8.

引用本文的文献

1
Design, Synthesis, and Characterization of New δ Opioid Receptor-Selective Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors.新型δ阿片受体选择性荧光探针的设计、合成与表征及其在野生型受体单分子显微镜中的应用
J Med Chem. 2024 Aug 8;67(15):12618-12631. doi: 10.1021/acs.jmedchem.4c00627. Epub 2024 Jul 23.
2
Adenosine A and A Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling.腺苷 A 和 A 受体能够相互作用。腺苷受体介导的信号转导之谜的又一环节。
Int J Mol Sci. 2020 Jul 17;21(14):5070. doi: 10.3390/ijms21145070.
3
Selective and Wash-Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single-Molecule Imaging of μ-Opioid Receptor Dimerization.
选择性和耐洗涤荧光二氢可待因酮衍生物可实现μ-阿片受体二聚体的单分子成像。
Angew Chem Int Ed Engl. 2020 Apr 6;59(15):5958-5964. doi: 10.1002/anie.201912683. Epub 2020 Jan 7.
4
Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis.颈动脉体中G蛋白偶联受体的受体-受体相互作用:一个工作假说。
Front Physiol. 2018 Jun 7;9:697. doi: 10.3389/fphys.2018.00697. eCollection 2018.
5
Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity.可利波立德是一种新型的κ-阿片受体偏向性激动剂,具有强大的止痒活性。
Proc Natl Acad Sci U S A. 2016 May 24;113(21):6041-6. doi: 10.1073/pnas.1521825113. Epub 2016 May 9.
6
Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.含N-苯基-N-(哌啶-2-基甲基)丙酰胺衍生物的脑啡肽类似物:合成与生物学评价
Bioorg Med Chem Lett. 2016 Jan 1;26(1):222-7. doi: 10.1016/j.bmcl.2015.10.081. Epub 2015 Nov 3.
7
Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.假定的κ阿片异聚体作为开发无不良反应镇痛药的靶点。
J Med Chem. 2014 Aug 14;57(15):6383-92. doi: 10.1021/jm500159d. Epub 2014 Jul 18.
8
Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors.作为独特的、功能性受体,μ/δ 阿片受体异源二聚体的分子透视。
Cells. 2014 Mar 5;3(1):152-79. doi: 10.3390/cells3010152.
9
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.G 蛋白偶联受体同型和异型二聚体的病理生理学:特别强调生长抑素受体。
Pharmaceuticals (Basel). 2012 Apr 27;5(5):417-46. doi: 10.3390/ph5050417.
10
Mu opioids and their receptors: evolution of a concept.μ 阿片类药物及其受体:概念的演变。
Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013.